Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic eye disease

L P Aiello1, J Cavallerano, S E Bursell

  • 1Joslin Diabetes Center, Boston, Massachusetts, USA.

Endocrinology and Metabolism Clinics of North America
|June 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-related behaviours in a remote Indigenous population with Type 2 diabetes: a Central Australian primary care survey in the Telehealth Eye and Associated Medical Services Network [TEAMSnet] project.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Influence of diabetes and diabetes type on anatomic and visual outcomes following central rein vein occlusion.

Eye (London, England)·2014
Same author

Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy.

Diabetologia·2013
Same author

Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction.

The British journal of ophthalmology·2009
Same author

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.

Eye (London, England)·2008
Same author

Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.

Ophthalmology·2007
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Diabetic retinopathy is a leading cause of vision loss in working-age adults. Early detection and treatment significantly reduce the risk of severe vision impairment from this diabetes complication.

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetology

Background:

  • Diabetic retinopathy is a major cause of visual impairment in the working-age population in the United States.
  • Diabetes mellitus is a chronic condition requiring ongoing management to prevent complications.

Purpose of the Study:

  • To provide a comprehensive overview of diabetic retinopathy.
  • To discuss current and emerging treatment strategies for diabetic retinopathy.

Main Methods:

  • Review of natural history, pathophysiology, and complications of diabetic retinopathy.
  • Analysis of current grading, evaluation, and treatment protocols.
  • Exploration of novel therapeutic approaches under investigation.

Main Results:

Related Experiment Videos

  • Diabetic retinopathy significantly impacts visual health in the working-age population.
  • Timely detection, evaluation, and treatment are crucial for mitigating severe vision loss.
  • Various treatment modalities exist, with ongoing research into novel interventions.

Conclusions:

  • Effective management of diabetic retinopathy can prevent severe visual loss.
  • Understanding the disease's progression and treatment options is vital for clinicians.
  • Emerging therapies hold promise for future management of diabetic retinopathy.